ROCKET PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.72 USD | -2.61% |
|
-3.20% | -24.19% |
| May. 10 | UBS Adjusts Rocket Pharmaceuticals Price Target to $51 From $54, Maintains Buy Rating | MT |
| May. 10 | Rocket Pharmaceuticals Says Blood Disorder Therapies Show Promise | MT |
Chart calendar Rocket Pharmaceuticals, Inc.
9a568a24f0522081d8afba1272a16.PJs277IPrbk0uYqaRx-p7qLIQH8Xtz2JaZ8MprOcolo.futmn_l94O9t1_isJlP-uMqeKTFR3Hb6MPtBk8n3yhcJyXeEg1jFjkPQsg~e040886194269cafcb231c5b7f73df79
Upcoming events on Rocket Pharmaceuticals, Inc.
Past events on Rocket Pharmaceuticals, Inc.
| 2024-05-10 03:00 pm | American Society of Gene & Cell Therapy Meeting - Donald B. Kohn |
| 2024-05-10 02:45 pm | American Society of Gene & Cell Therapy Meeting - Agnieszka Czechowicz |
| 2024-05-08 08:00 am | American Society of Gene & Cell Therapy Meeting - Julián Sevilla |
| 2024-05-06 04:01 pm | Q1 2024 Earnings Release |
| 2024-04-08 | Needham Healthcare Conference |
| 2024-03-12 08:00 am | Leerink Partners Global Biopharma Conference |
| 2024-03-06 | Q4 2023 Earnings Release (Projected) |
| 2024-03-05 02:10 pm | TD Cowen Health Care Conference |
| 2024-01-08 06:45 pm | JPMorgan Healthcare Conference |
| 2023-11-30 01:20 pm | Evercore ISI HealthCONx Conference |
| 2023-11-15 10:55 am | Stifel Healthcare Conference |
| 2023-11-06 04:04 pm | Q3 2023 Earnings Release |
| 2023-10-27 05:00 am | European Society of Gene and Cell Therapy Conference - Jonathan Schwartz |
| 2023-10-26 02:30 pm | European Society of Gene and Cell Therapy Conference - Poster Number: P067 |
| 2023-10-26 03:00 am | European Society of Gene and Cell Therapy Conference - Paula Río |
| 2023-10-25 11:00 am | European Society of Gene and Cell Therapy Conference - Poster Number: P067 |
| 2023-10-25 08:30 am | European Society of Gene and Cell Therapy Conference - Kinnari Patel |
| 2023-10-24 11:00 am | European Society of Gene and Cell Therapy Conference - Julián Sevilla |
| 2023-10-10 | Cell & Gene Meeting on the Mesa Conference |
| 2023-10-03 01:00 pm | Chardan Genetic Medicines Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,10 - | 0,00 0,00 - | 19,7 |
|
EBITDA Million USD | Released Forecast Spread | -76,1 -91,0 16.43% | -133 -102 -30.77% | -164 -153 -7.29% | -189 -193 2% | -255 -266 4.08% | -233 |
|
EBIT Million USD | Released Forecast Spread | -76,2 -82,7 7.93% | -134 -104 -28.96% | -167 -170 1.59% | -224 -214 -4.71% | -260 -265 2.14% | -282 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -77,3 -84,7 8.82% | -140 -110 -27.56% | -169 -172 1.52% | -222 -216 -2.78% | -246 -252 2.72% | -267 |
|
Net income Million USD | Released Forecast Spread | -77,3 -84,1 8.08% | -140 -109 -27.86% | -169 -172 1.46% | -222 -215 -3.01% | -246 -253 2.94% | -274 |
|
EPS USD | Released Forecast Spread | -1,58 -1,68 5.7% | -2,52 -1,93 -30.29% | -2,67 -2,64 -1.21% | -3,26 -3,14 -3.8% | -2,92 -3,00 2.81% | -2,79 |
| Announcement Date | 05/03/20 | 25/02/21 | 24/02/22 | 27/02/23 | 26/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 4,39 | 25,5 | 19,1 | 19,9 |
|
EBITDA Million USD | Released Forecast Spread | -53,2 -43,6 -22.08% | -49,7 -47,5 -4.77% | -58,3 -45,3 -28.67% | -52,1 -55,4 5.92% | -57,3 -65,6 12.57% | -53,9 -70,5 23.53% | -61,9 -73,6 15.95% | -65,7 -63,7 -3.09% | -65,9 | -57,4 | -43,8 | |||
|
EBIT Million USD | Released Forecast Spread | -42,6 -48,0 11.39% | -54,2 -44,4 -21.97% | -58,5 -53,5 -9.25% | -69,1 -59,3 -16.41% | -62,2 -65,4 4.95% | -68,8 -63,2 -8.83% | -65,4 -72,5 9.72% | -63,3 -69,0 8.3% | -67,4 -63,9 -5.37% | -69,3 | -69,2 | -67,3 | -54,6 | -55,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -43,0 -47,0 8.45% | -54,4 -44,6 -21.91% | -57,8 -54,6 -5.73% | -66,7 -60,6 -10.07% | -58,3 -64,0 8.87% | -65,7 -61,8 -6.31% | -61,9 -69,3 10.62% | -59,7 -66,7 10.57% | -62,1 -64,3 3.46% | -67,2 | -67,4 | -65,5 | -54,6 | -55,5 |
|
Net income Million USD | Released Forecast Spread | -43,0 -46,7 8.01% | -54,4 -44,5 -22.37% | -57,8 -52,4 -10.19% | -66,7 -60,1 -11.11% | -58,3 -64,6 9.72% | -65,7 -62,9 -4.48% | -61,9 -68,8 10.03% | -59,7 -66,9 10.83% | -62,1 -61,1 -1.64% | -68,6 | -68,8 | -67,6 | -54,6 | -55,5 |
|
EPS USD | Released Forecast Spread | -0,67 -0,70 4.72% | -0,83 -0,68 -21.55% | -0,87 -0,79 -9.48% | -0,89 -0,82 -8.33% | -0,73 -0,82 11.41% | -0,82 -0,79 -3.78% | -0,75 -0,80 6.64% | -0,64 -0,78 17.72% | -0,66 -0,67 1.43% | -0,72 | -0,72 | -0,71 | -0,54 | -0,51 |
| Announcement Date | 05/05/22 | 08/08/22 | 03/11/22 | 27/02/23 | 04/05/23 | 09/08/23 | 07/11/23 | 26/02/24 | 06/05/24 | - | - | - | - | - |
More events
Past sector events for Rocket Pharmaceuticals, Inc.
| 2024-05-10 04:02 pm | CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-10 08:26 am | ITEOS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-10 08:00 am | PRIME MEDICINE, INC.: Q1 2024 Earnings Release |
| 2024-05-10 07:00 am | AKERO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 08:05 pm | SOLENO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-09 04:15 pm | ANAPTYSBIO, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:10 pm | ASTRIA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:09 pm | XENCOR, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | STRUCTURE THERAPEUTICS INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RCKT Stock
- Calendar Rocket Pharmaceuticals, Inc.
